These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 30613271)

  • 1. Radiomic signature of
    Jiang Y; Yuan Q; Lv W; Xi S; Huang W; Sun Z; Chen H; Zhao L; Liu W; Hu Y; Lu L; Ma J; Li T; Yu J; Wang Q; Li G
    Theranostics; 2018; 8(21):5915-5928. PubMed ID: 30613271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer.
    Jiang Y; Chen C; Xie J; Wang W; Zha X; Lv W; Chen H; Hu Y; Li T; Yu J; Zhou Z; Xu Y; Li G
    EBioMedicine; 2018 Oct; 36():171-182. PubMed ID: 30224313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a machine learning-based
    Zhi H; Xiang Y; Chen C; Zhang W; Lin J; Gao Z; Shen Q; Shao J; Yang X; Yang Y; Chen X; Zheng J; Lu M; Pan B; Dong Q; Shen X; Ma C
    Cancer Imaging; 2024 Jul; 24(1):99. PubMed ID: 39080806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a Radiomics Nomogram Based on
    Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
    Front Oncol; 2020; 10():1042. PubMed ID: 32766134
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiomics analysis of [
    Li Y; Zhang Y; Fang Q; Zhang X; Hou P; Wu H; Wang X
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2599-2614. PubMed ID: 33416951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive measurement of tumor immune microenvironment and prediction of survival and chemotherapeutic benefits from
    Li J; Zhang C; Guo H; Li S; You Y; Zheng P; Zhang H; Wang H; Bai J
    Front Immunol; 2022; 13():1019386. PubMed ID: 36311742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of
    Song Y; Tian Y; Lu X; Chen G; Lv X
    Med Phys; 2024 Jul; 51(7):4907-4921. PubMed ID: 38252704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Overall Survival and Progression-Free Survival by the
    Zhou Y; Ma XL; Pu LT; Zhou RF; Ou XJ; Tian R
    Contrast Media Mol Imaging; 2019; 2019():5963607. PubMed ID: 31777473
    [No Abstract]   [Full Text] [Related]  

  • 9. Preoperative computed tomography-guided disease-free survival prediction in gastric cancer: a multicenter radiomics study.
    Wang S; Feng C; Dong D; Li H; Zhou J; Ye Y; Liu Z; Tian J; Wang Y
    Med Phys; 2020 Oct; 47(10):4862-4871. PubMed ID: 32592224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer.
    Jia T; Lv Q; Cai X; Ge S; Sang S; Zhang B; Yu C; Deng S
    Front Oncol; 2023; 13():1210125. PubMed ID: 37576897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of an
    Wang H; Zhao S; Li L; Tian R
    Eur Radiol; 2020 Oct; 30(10):5578-5587. PubMed ID: 32435928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics model based on preoperative 18F-fluorodeoxyglucose PET predicts N2-3b lymph node metastasis in gastric cancer patients.
    Xue XQ; Yu WJ; Shao XL; Li XF; Niu R; Zhang FF; Shi YM; Wang YT
    Nucl Med Commun; 2022 Mar; 43(3):340-349. PubMed ID: 34954765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining the radiomic features and traditional parameters of
    Chen YH; Lue KH; Chu SC; Chang BS; Wang LY; Liu DW; Liu SH; Chao YK; Chan SC
    Ann Nucl Med; 2019 Sep; 33(9):657-670. PubMed ID: 31218571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomic analysis for preoperative prediction of cervical lymph node metastasis in patients with papillary thyroid carcinoma.
    Lu W; Zhong L; Dong D; Fang M; Dai Q; Leng S; Zhang L; Sun W; Tian J; Zheng J; Jin Y
    Eur J Radiol; 2019 Sep; 118():231-238. PubMed ID: 31439247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomic signature-based nomogram to predict disease-free survival in stage II and III colon cancer.
    Yao X; Sun C; Xiong F; Zhang X; Cheng J; Wang C; Ye Y; Hong N; Wang L; Liu Z; Meng X; Wang Y; Tian J
    Eur J Radiol; 2020 Oct; 131():109205. PubMed ID: 32871292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma.
    Yuan Y; Ren J; Shi Y; Tao X
    Eur J Radiol; 2019 Aug; 117():193-198. PubMed ID: 31307647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Assessment for Event-Free Survival With Hepatoblastoma in Pediatric Patients by Developing a CT-Based Radiomics Model.
    Jiang Y; Sun J; Xia Y; Cheng Y; Xie L; Guo X; Guo Y
    Front Oncol; 2021; 11():644994. PubMed ID: 33937051
    [No Abstract]   [Full Text] [Related]  

  • 18. Development and validation of an [
    Takahashi N; Tanaka S; Umezawa R; Takanami K; Takeda K; Yamamoto T; Suzuki Y; Katsuta Y; Kadoya N; Jingu K
    Acta Oncol; 2023 Feb; 62(2):159-165. PubMed ID: 36794365
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Chen H; Chen Y; Dong Y; Gou L; Hu Y; Wang Q; Li G; Li S; Yu J
    Ann Surg Oncol; 2024 Sep; 31(9):6017-6027. PubMed ID: 38976160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics Signature on Computed Tomography Imaging: Association With Lymph Node Metastasis in Patients With Gastric Cancer.
    Jiang Y; Wang W; Chen C; Zhang X; Zha X; Lv W; Xie J; Huang W; Sun Z; Hu Y; Yu J; Li T; Zhou Z; Xu Y; Li G
    Front Oncol; 2019; 9():340. PubMed ID: 31106158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.